Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion type Assertion NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_head.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion evidence source_evidence_literature NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion SIO_000772 18577985 NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion wasDerivedFrom lhgdn-20090331 NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.
- NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_assertion wasGeneratedBy ECO_0000203 NP104094.RAZqQWdQAlvev4sv99OgFy6vb4qqm6eeGQA8u5AgiaGX4130_provenance.